Internal Medicine, Infectious Disease · Chandler, AZ
NPI
1619189800
Since 2007
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2201 W Fairview St Ste 9
Chandler, AZ, 85224
Phone (480) 470-4000
Groups this clinician bills Medicare through
Medicare paid, 2024
$89K
1,279 services
Medicare patients, 2024
430
Average age 72
Drug cost, 2024
$4.1M
1,039 prescriptions
Company payments, 2025
$164K
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anita Kohli was code 99214 (office e&m - established), 442 times for 291 patients. In total Anita Kohli billed 1,279 services in 12 codes, and Medicare paid $89K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-05-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 442 | 291 | $89.35 | $39K |
| 76981 Ultrasound - Nonspecific | Office | 371 | 297 | $75.00 | $28K |
| 36415 Venipuncture Blood Collection | Office | 210 | 160 | $7.01 | $1,473 |
| 99204 Office E&M - New | Office | 108 | 108 | $109.51 | $12K |
| 99213 Office E&M - Established | Office | 72 | 67 | $62.89 | $4,528 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 31 | 31 | $12.21 | $379 |
| 76700 Ultrasound - Abdomen and Pelvis | Office | 26 | 19 | $79.37 | $2,064 |
By year: 2022 $77K for 833 services; 2023 $95K for 1,330 services; 2024 $89K for 1,279 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 210 | 160 | $7.01 | $1,473 |
Medicare prescription drug claims, 2024
In 2024, the drug Anita Kohli prescribed most often to Medicare patients was Xifaxan (Rifaximin), with 214 prescriptions and refills. In total Anita Kohli wrote 1,039 Medicare prescriptions that cost $4.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Xifaxan Rifaximin | 214 | 228 | 41 | $736K |
| Ursodiol Generic | 132 | 227 | 35 | $21K |
| Lactulose Generic | 111 | 155 | 50 | $2,093 |
| Epclusa Sofosbuvir/Velpatasvir | 103 | 103 | 34 | $2.6M |
| Furosemide Generic | 65 | 99 | 26 | $206 |
| Spironolactone Generic | 62 | 92 | 26 | $627 |
| Carvedilol Generic | 53 | 104 | 18 | $365 |
| Azathioprine Generic | 37 | 74 | Under 11 | $2,481 |
| Vemlidy Tenofovir Alafenamide | 35 | 35 | Under 11 | $59K |
| Rezdiffra Resmetirom | 31 | 35 | Under 11 | $138K |
| Ocaliva Obeticholic Acid | 26 | 32 | Under 11 | $289K |
| Prednisone Generic | 14 | 24 | Under 11 | $129 |
| Mycophenolate Mofetil Generic | 11 | 15 | Under 11 | $276 |
| Ozempic Semaglutide | 11 | 19 | Under 11 | $18K |
Brand drugs: 485 claims; generic drugs: 554 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anita Kohli $164K ($164K in general payments such as food, travel and fees) from 26 companies. The largest payer was Madrigal Pharmaceuticals with $151K.
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals MDGL | 25 | $151K |
| Gilead Sciences, Inc. GILD | 22 | $12K |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $1,334 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 5 | $147 |
| Abbvie Inc. ABBV | 2 | $71.5 |
| Pfizer Inc. PFE | 1 | $69.19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 2 | $44.24 |
| Novo Nordisk Inc NVO | 1 | $32.27 |
| Invivyd Inc IVVD | 1 | $24.02 |
| Mirum Pharmaceuticals, Inc. MIRM | 1 | $23.03 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.